Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Emerald Resources NL ( (AU:EMR) ) has provided an announcement.
State Street Corporation and several of its asset management and trust subsidiaries, including State Street Global Advisors entities in Australia, Europe and the U.S., have lodged a notice that they have ceased to be a substantial holder in Emerald Resources NL as of 16 March 2026. The change, disclosed under section 671B of the Corporations Act, signals a reduction in State Street’s voting interest and may slightly alter the company’s institutional investor profile, though no specific transaction details or consideration amounts are provided in the filing.
While the form lists multiple related State Street entities and their addresses across Boston, Sydney, London and Dublin, it does not specify the precise quantum of securities affected or the nature of any agreements behind the change. The notice primarily serves as a regulatory compliance update for the market, indicating that State Street’s aggregated holdings have fallen below the substantial shareholder threshold in Emerald Resources, with limited immediate operational implications disclosed for the company or other stakeholders.
The most recent analyst rating on (AU:EMR) stock is a Buy with a A$6.50 price target. To see the full list of analyst forecasts on Emerald Resources NL stock, see the AU:EMR Stock Forecast page.
More about Emerald Resources NL
Emerald Resources NL is an Australian-listed company operating in the resources sector, with its shares subject to substantial holding disclosure requirements under the Corporations Act 2001. The company’s register includes international institutional investors and custodians, reflecting a level of global interest in its equity.
Average Trading Volume: 1,745,450
Technical Sentiment Signal: Buy
Current Market Cap: A$3.82B
See more insights into EMR stock on TipRanks’ Stock Analysis page.

